Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Therapeutic Advances in Infectious Disease
|
May 20, 2022
The use of technology-based adherence monitoring in the treatment of hepatitis C virus
Yeba H Adje, Kristina M Brooks, Jose R Castillo-Mancilla, et al.
Health & Justice
|
July 11, 2024
Hepatitis C-related knowledge and attitude among adults on probation in a large US city
Matthew S Minturn, Kevin F Kamis, David L Wyles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2012
Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches
Sergey M Dibrov, Kejia Ding, Nicholas D Brunn, et al.
Journal of Virology & Antiviral Research
|
November 24, 2015
Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression
Julio A Gutierrez, Krysten A Jones, Roxana Flores, et al.
Open Forum Infectious Diseases
|
August 15, 2020
Use of a Standardized Dalbavancin Approach to Facilitate Earlier Hospital Discharge for Vulnerable Patients Receiving Prolonged Inpatient Antibiotic Therapy
Axel A Vazquez Deida, Katherine C Shihadeh, Candice R Preslaski, et al.
Bioorganic & Medicinal Chemistry
|
July 2, 2011
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication
Nadejda Valiaeva, David L Wyles, Robert T Schooley, et al.
Open Forum Infectious Diseases
|
February 3, 2022
Hepatitis C Testing and Linkage to Care Among Adults on Probation in a Large US City
Kevin F Kamis, David L Wyles, Matthew S Minturn, et al.
AIDS (London, England)
|
July 12, 2013
High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen
Edward R Cachay, David L Wyles, Francesca J Torriani, et al.
Hepatology (Baltimore, Md.)
|
July 7, 2015
Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection
Aaron F Carlin, Paula Aristizabal, Qinghua Song, et al.
Alimentary Pharmacology & Therapeutics
|
May 1, 2020
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence
Mark Sulkowski, Annie F Luetkemeyer, David L Wyles, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Therapeutic Advances in Infectious Disease
|
May 20, 2022
The use of technology-based adherence monitoring in the treatment of hepatitis C virus
Yeba H Adje, Kristina M Brooks, Jose R Castillo-Mancilla, et al.
Health & Justice
|
July 11, 2024
Hepatitis C-related knowledge and attitude among adults on probation in a large US city
Matthew S Minturn, Kevin F Kamis, David L Wyles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2012
Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches
Sergey M Dibrov, Kejia Ding, Nicholas D Brunn, et al.
Journal of Virology & Antiviral Research
|
November 24, 2015
Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression
Julio A Gutierrez, Krysten A Jones, Roxana Flores, et al.
Open Forum Infectious Diseases
|
August 15, 2020
Use of a Standardized Dalbavancin Approach to Facilitate Earlier Hospital Discharge for Vulnerable Patients Receiving Prolonged Inpatient Antibiotic Therapy
Axel A Vazquez Deida, Katherine C Shihadeh, Candice R Preslaski, et al.
Bioorganic & Medicinal Chemistry
|
July 2, 2011
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication
Nadejda Valiaeva, David L Wyles, Robert T Schooley, et al.
Open Forum Infectious Diseases
|
February 3, 2022
Hepatitis C Testing and Linkage to Care Among Adults on Probation in a Large US City
Kevin F Kamis, David L Wyles, Matthew S Minturn, et al.
AIDS (London, England)
|
July 12, 2013
High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen
Edward R Cachay, David L Wyles, Francesca J Torriani, et al.
Hepatology (Baltimore, Md.)
|
July 7, 2015
Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection
Aaron F Carlin, Paula Aristizabal, Qinghua Song, et al.
Alimentary Pharmacology & Therapeutics
|
May 1, 2020
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence
Mark Sulkowski, Annie F Luetkemeyer, David L Wyles, et al.
Page
of 8